profit from every $100 of sales.
$0$100
Intuitive Surgical
$443.59+0.84% today
-21.6% in 1 year
1-year low $332.021-year high $592.85
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $53.84 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Intuitive Surgical sold, what it kept, and what it did with the cash.
Sales went from $6.22 billion in 2022 to $10.1 billion in 2025, with $2.86 billion of profit last year.
SalesProfit
Intuitive Surgical handed back 92% of the cash it generated last year.
Buybacks $2.3B
Free cash flow 2025$2.5B
Bought back its own shares$2.3B
Paid as dividends–
Intuitive Surgical vs. similar companies
Intuitive Surgical grows the fastest of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Intuitive Surgical | 53.8× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 35.4× · Expensive | ||
 Medline | 44.8× · Expensive | ||
 HOYA | 39.3× · Expensive |
Compare Intuitive Surgical with AbbVie · Amgen · Bristol-Myers Squibb · Edwards Lifesciences · Johnson & Johnson · Eli Lilly · Medtronic · Merck &
AI analysis
An AI analyst reads Intuitive Surgical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 4,358 | 5,710 | 6,222 | 7,124 | 8,352 | 10,065 | |
| 2,861 | 3,959 | 4,196 | 4,730 | 5,634 | 6,642 | |
| 1,050 | 1,821 | 1,577 | 1,767 | 2,349 | 2,946 | |
| 1,321 | 2,128 | 1,943 | 2,222 | 2,849 | 3,623 | |
| 1,061 | 1,705 | 1,322 | 1,798 | 2,323 | 2,856 | |
| 2.94 | 4.66 | 3.65 | 5.03 | 6.42 | 7.87 | |
| 65.6% | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% | |
| 24.1% | 31.9% | 25.3% | 24.8% | 28.1% | 29.3% | |
| 24.3% | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 11,169 | 13,555 | 12,974 | 15,442 | 18,743 | 20,459 |
| Cash | 1,623 | 1,291 | 1,581 | 2,750 | 2,027 | 3,368 |
| Total debt | – | – | – | – | – | – |
| Total liabilities | 1,410 | 1,604 | 1,861 | 2,044 | 2,214 | 2,517 |
| 9,732 | 11,901 | 11,042 | 13,308 | 16,434 | 17,824 | |
| 361 | 366 | 362 | 357 | 362 | 363 | |
| 8.5% | 12.1% | 11.3% | 10.5% | 11.3% | 13.1% | |
| 10.9% | 14.3% | 12.0% | 13.5% | 14.1% | 16.0% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 1,485 | 2,089 | 1,491 | 1,814 | 2,415 | 3,031 | |
| 342 | 340 | 532 | 1,064 | 1,111 | 540 | |
| 1,143 | 1,750 | 958 | 750 | 1,304 | 2,491 | |
| Dividends paid | – | – | – | – | – | – |
| 134 | 0 | 2,607 | 416 | 0 | 2,295 | |
| 395 | 449 | 513 | 593 | 677 | 788 |
Valuation
- 53.8×
- 42.8×
- 2.47
- 8.7×
- 15.3×
- 61.7×
- 41.5×
- 1.6%
- 1.9%
- 0.0%
Profitability
- 66.0%
- 29.3%
- 28.4%
- 35.5%
- 13.4%
- 11.8%
- 17.0%
- 14.8%
- 17.7%
- 12.8%
Growth
- +18.2%
- +21.8%
- +91.0%
- –
- +0.1%
Financial health
- -0.9×
- 0.00
- 0.0%
- –
- 4.87
- 5.01
- 0.53
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 18%of 946
Top 11%of 872
Bottom 20%of 563
Top 32%of 868
Top 46%of 986
What analysts expect
- Average price target
- $622.60
- Range
- $525.00 – $750.00
- 4 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 21, 2026 | 2.50 | 2.12 | +17.9% |
| Jan 22, 2026 | 2.53 | 2.27 | +11.5% |
| Oct 21, 2025 | 2.40 | 1.99 | +20.6% |
| Jul 22, 2025 | 2.19 | 1.93 | +13.5% |
| Apr 22, 2025 | 1.81 | 1.74 | +4.0% |
| Jan 23, 2025 | 2.21 | 1.76 | +25.6% |
| Oct 17, 2024 | 1.84 | 1.63 | +12.9% |
| Jul 18, 2024 | 1.78 | 1.54 | +15.6% |
News
What Is Driving Intuitive Machines Stock?Yahoo Finance · Nov 13, 2026Is Intuitive Surgical's Next Big Thing Already Here?Yahoo Finance · Nov 7, 2026Is Intuitive Surgical Stock's Market Price Justified?Yahoo Finance · Oct 29, 2026Intuitive narrows 2026 procedure growth outlook to 14%-15% amid I&A pricing actions targeting 3%-5% per-procedure reductionSeeking Alpha · Oct 21, 2026Intuitive Surgical (ISRG) Stock Is Down 25% Year to Date. History Says Patient Investors Get Rewarded.Yahoo Finance · Oct 17, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
5/7Passes 5 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
61Pass
Benjamin Graham
50No pass
Philip Fisher
76Pass
Peter Lynch
64Pass
Joel Greenblatt
14No pass
Charlie Munger
66Pass
Terry Smith
60Pass
Questions about Intuitive Surgical
Is Intuitive Surgical a good stock to buy?
A strong, very profitable business, but the price is high. 5 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Intuitive Surgical AI analysis
What does Intuitive Surgical do?
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It is in Medical Instruments & Supplies, based in Sunnyvale, CA, United States, with 17,021 employees.
Does Intuitive Surgical pay a dividend?
No. Intuitive Surgical does not pay a dividend at the moment; in 2025 it returned $2.30 billion to shareholders by buying back its own shares.
Is Intuitive Surgical stock halal?
Yes. Intuitive Surgical passes our halal screen: its business is permitted and its debt is under 0.1% of its market value, under the 30% limit. How we check
How has Intuitive Surgical stock done over the past year?
Down 21.6% over the past twelve months, to $443.59. It traded between $332.02 and $592.85 and is 25.2% below its high.
Who are Intuitive Surgical's competitors?
The largest listed companies in the same industry are EssilorLuxottica Société anonyme, Becton, Dickinson and, Medline and HOYA. The peers table on this page compares their profit, growth and price with Intuitive Surgical's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.